EMIS Health is one of just two suppliers on the £15m NHS Scotland HEPMA framework (which is rolling out electronic medicines management across hospitals). It means that health boards are free to choose EMIS Health’s fully integrated suite of HEPMA eprescribing, medicines management and hospital pharmacy systems. The technology uses intuitive touch screens with a drug chart layout that is familiar to clinicians, and allows them to prescribe according to their current practice rather than having to adapt to the constraints of an electronic system.
EMIS Health’s hospital pharmacy system is already used in seven health boards, and the company has a 51.5% share of the GP market in Scotland.
Duane Lawrence, Managing Director for EMIS Health secondary care said: “We are delighted to have landed this important business win, which shows our reach across the UK.
“North and south of the border, our systems are driving up standards of patient care, transforming ways of working for clinicians and introducing efficiencies that will save the NHS money.”